HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Niccolò Bolli Selected Research

Multiple Myeloma

12/2023Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma.
11/2023Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures.
9/2023The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma.
1/2023Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins.
1/2023Response to SARS-CoV-2 vaccination and antibodies persistence in multiple myeloma patients.
1/2023Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma.
12/2022Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple Myeloma.
12/2022Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant.
11/2022Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myeloma.
2/2022The Dynamics of Nucleotide Variants in the Progression from Low-Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing Approach.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Niccolò Bolli Research Topics

Disease

15Multiple Myeloma
12/2023 - 01/2020
14Neoplasms (Cancer)
03/2024 - 01/2004
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2023 - 06/2006
3Chromothripsis
01/2024 - 11/2021
2Plasma Cell Leukemia
09/2021 - 12/2007
2Residual Neoplasm
05/2008 - 04/2007
1Familial cerebral cavernous malformation
12/2023
1Paraproteinemias (Monoclonal Gammopathy)
11/2023
1POEMS Syndrome (Syndrome, POEMS)
11/2023
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2023
1Autosomal Dominant Rhegmatogenous Retinal Detachment
12/2022
1VEXAS syndrome
06/2022
1Hematologic Neoplasms (Hematological Malignancy)
11/2021
1Carcinogenesis
06/2021
1Multiple Abnormalities
12/2007
1Ventricular Tachycardia
12/2007
1Syncope (Fainting)
12/2007
1Lymphoma (Lymphomas)
04/2007
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
04/2007
1Leukemia
04/2007
1Myeloid Sarcoma (Chloroma)
04/2006

Drug/Important Bio-Agent (IBA)

10NucleophosminIBA
01/2011 - 04/2006
4Biomarkers (Surrogate Marker)IBA
12/2023 - 01/2021
4Proteins (Proteins, Gene)FDA Link
11/2023 - 04/2005
3DNA (Deoxyribonucleic Acid)IBA
03/2024 - 08/2013
2Monoclonal AntibodiesIBA
12/2023 - 04/2005
2Melphalan (Alkeran)FDA LinkGeneric
11/2023 - 12/2022
2AntibodiesIBA
01/2023 - 04/2007
2NucleotidesIBA
01/2023 - 02/2022
2Nuclear Proteins (Protein, Nuclear)IBA
11/2022 - 05/2008
2ParaffinIBA
11/2021 - 09/2006
1Adenosine Monophosphate (AMP)IBA
01/2024
1daratumumabIBA
11/2023
1Antineoplastic Agents (Antineoplastics)IBA
11/2023
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2023
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2023
1ElementsIBA
11/2023
1Lenalidomide (CC 5013)FDA Link
11/2023
1luspaterceptIBA
11/2023
1PlatinumIBA
11/2023
1CytokinesIBA
11/2023
1LigandsIBA
09/2023
1Long Noncoding RNAIBA
01/2023
1Proteasome InhibitorsIBA
01/2023
1Small Cytoplasmic RNAIBA
12/2022
1RNA (Ribonucleic Acid)IBA
12/2022
1Glucose (Dextrose)FDA LinkGeneric
11/2022
1Azacitidine (5 Azacytidine)FDA Link
06/2022
1Protein Isoforms (Isoforms)IBA
11/2021
1Immunomodulating AgentsIBA
11/2021
1Antisense OligonucleotidesIBA
11/2021
1Formaldehyde (Formol)FDA Link
11/2021
1venetoclaxIBA
09/2021
1Mitochondrial DNA (mtDNA)IBA
06/2021
1Circulating Tumor DNAIBA
08/2020
1thiamine triphosphorate (TTP)IBA
01/2020
1CytidineIBA
08/2013
1PhosphoproteinsIBA
04/2010
1Thalidomide (Thalomid)FDA Link
12/2007
1Nuclear Export Signals (Nuclear Export Signal)IBA
07/2007
1Anaplastic Lymphoma KinaseIBA
04/2007
1Annexin A6IBA
04/2005
1polyacrylamideIBA
04/2005
1Alemtuzumab (Campath)FDA Link
01/2004

Therapy/Procedure

5Therapeutics
12/2023 - 08/2013
2Drug Therapy (Chemotherapy)
11/2023 - 02/2015
1Stem Cell Transplantation
11/2023
1Immunotherapy
12/2021
1Molecular Targeted Therapy
05/2008